Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
The Oncologist
|
September 2, 2018
Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin Analogs
Barbara Kiesewetter, Heying Duan, Wolfgang Lamm, et al.
Journal of Clinical Medicine
|
December 17, 2024
Hypotension with and Without Hypertensive Episodes During Endoscopic Adrenalectomy for Pheochromocytoma or Paraganglioma-Should Perioperative Treatment Be Individualized?
Akos Tiboldi, Jonas Gernhold, Christian Scheuba, et al.
Orphanet Journal of Rare Diseases
|
February 24, 2019
Intertumor heterogeneity in 60 pancreatic neuroendocrine tumors associated with multiple endocrine neoplasia type 1
Andreas Selberherr, Oskar Koperek, Philipp Riss, et al.
Current Problems in Surgery
|
November 22, 2023
Viability and Functionality of Human Cryopreserved Parathyroid Tissue (PT): Long-Term Results of a Large In Vitro Study
Lindsay Hargitai, Irene Steiner, Vanessa Schimek, et al.
Endocrine-Related Cancer
|
June 2, 2026
B7-H3 (CD276) as a Candidate Therapeutic Target in Medullary Thyroid Cancer
Teresa Binter, Erwin Tomasich, Philipp Melhorn, et al.
Annals of Surgical Oncology
|
October 12, 2018
Medullary Thyroid Carcinoma: Do Ultrasonography and F-DOPA-PET-CT Influence the Initial Surgical Strategy?
Lindsay Brammen, Martin B Niederle, Philipp Riss, et al.
Biochemia Medica
|
November 16, 2018
Calcium-stimulated calcitonin - The "new standard" in the diagnosis of thyroid C-cell disease - clinically relevant gender-specific cut-off levels for an "old test"
Martin B Niederle, Christian Scheuba, Alois Gessl, et al.
Langenbeck'S Archives of Surgery
|
August 28, 2019
Effectiveness of anti-osteoporotic treatment after successful parathyroidectomy for primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial
Martin B Niederle, Ursula Foeger-Samwald, Philipp Riss, et al.
Endocrine
|
November 24, 2018
Factors predicting long-term comorbidities in patients with Cushing's syndrome in remission
Marie Helene Schernthaner-Reiter, Christina Siess, Alois Gessl, et al.
Endocrine
|
January 26, 2019
Correction to: Factors predicting long-term comorbidities in patients with Cushing's syndrome in remission
Marie Helene Schernthaner-Reiter, Christina Siess, Alois Gessl, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
The Oncologist
|
September 2, 2018
Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin Analogs
Barbara Kiesewetter, Heying Duan, Wolfgang Lamm, et al.
Journal of Clinical Medicine
|
December 17, 2024
Hypotension with and Without Hypertensive Episodes During Endoscopic Adrenalectomy for Pheochromocytoma or Paraganglioma-Should Perioperative Treatment Be Individualized?
Akos Tiboldi, Jonas Gernhold, Christian Scheuba, et al.
Orphanet Journal of Rare Diseases
|
February 24, 2019
Intertumor heterogeneity in 60 pancreatic neuroendocrine tumors associated with multiple endocrine neoplasia type 1
Andreas Selberherr, Oskar Koperek, Philipp Riss, et al.
Current Problems in Surgery
|
November 22, 2023
Viability and Functionality of Human Cryopreserved Parathyroid Tissue (PT): Long-Term Results of a Large In Vitro Study
Lindsay Hargitai, Irene Steiner, Vanessa Schimek, et al.
Endocrine-Related Cancer
|
June 2, 2026
B7-H3 (CD276) as a Candidate Therapeutic Target in Medullary Thyroid Cancer
Teresa Binter, Erwin Tomasich, Philipp Melhorn, et al.
Annals of Surgical Oncology
|
October 12, 2018
Medullary Thyroid Carcinoma: Do Ultrasonography and F-DOPA-PET-CT Influence the Initial Surgical Strategy?
Lindsay Brammen, Martin B Niederle, Philipp Riss, et al.
Biochemia Medica
|
November 16, 2018
Calcium-stimulated calcitonin - The "new standard" in the diagnosis of thyroid C-cell disease - clinically relevant gender-specific cut-off levels for an "old test"
Martin B Niederle, Christian Scheuba, Alois Gessl, et al.
Langenbeck'S Archives of Surgery
|
August 28, 2019
Effectiveness of anti-osteoporotic treatment after successful parathyroidectomy for primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial
Martin B Niederle, Ursula Foeger-Samwald, Philipp Riss, et al.
Endocrine
|
November 24, 2018
Factors predicting long-term comorbidities in patients with Cushing's syndrome in remission
Marie Helene Schernthaner-Reiter, Christina Siess, Alois Gessl, et al.
Endocrine
|
January 26, 2019
Correction to: Factors predicting long-term comorbidities in patients with Cushing's syndrome in remission
Marie Helene Schernthaner-Reiter, Christina Siess, Alois Gessl, et al.
Page
of 7